Shinta Oktya Wardhani, - and Jonny Karunia Fajar, - and Nina Nurarifah, - and Djoko Heri Hermanto, - and Siti Fatonah, - and Susanthy Djajalaksana, - and Arie Zainul Fatoni, - and Putu Moda Arsana, - and Laksmi Wulandari, - and Gatot Soegiarto, - and Kuldeep Dhama, - and Harapan, - (2021) The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors. Clinical Epidemiology and Global Health, 11 (100763). pp. 1-4. ISSN 22133984

	Text (Similarity) 2. Turnitin_Artikel 20.pdf Download (1MB)
	Text (Artikel) 1. Full Text_Artikel 20.pdf Download (3MB)
	Text (Peer Review) Karil Artikel 20.pdf Download (656kB)
	Text (Peer Review) 1.Karil_14.pdf Download (360kB)
	Text (Bukti Korespondensi) 4. Korespondensi_14.pdf Download (1MB)

Abstract

Background Recent evidence suggested that the higher titers of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody from convalescent plasma donors contributed to the clinical improvement in coronavirus disease 2019 (COVID-19) patients. However, the titers of anti-SARS-CoV-2 antibodies varied in each individual, and the precise factors that might govern such variation have not been elucidated. Objectives To assess the factors associated with high titers of anti-SARS-CoV-2 antibody among COVID-19 convalescent plasma (CCP) donors. Methods A cross-sectional study was conducted in Saiful Anwar General Hospital, Malang, Indonesia. Information of interest including demographic characteristics, clinical symptoms, comorbidities, laboratory findings, and the titers of anti-SARS-CoV-2 antibody among COVID-19 CCP donors were collected. The correlation was assessed using multiple logistic regression. Results A total of 50 COVID-19 CCP donors with the titers of anti-SARS-CoV-2 antibody of more than 1:320 and 33 donors with the titers of less than 1:320 were analyzed. Our analysis revealed that CCP donors with history of cough, fever, dyspnea, and pneumonia significantly had higher titers of anti-SARS-CoV-2 antibody compared to asymptomatic donors. Moreover, CCP donors with elevated levels of eosinophils and immature granulocytes and low levels of albumins had higher levels of anti-SARS-CoV-2 antibody. The titer of antibody was not affected by comorbidities of donors. Conclusions CPP donors who had experience of symptomatic COVID-19 with high eosinophils level, high immature granulocytes and low albumin level have higher titers of anti-SARS-COV-2 antibody than those who experienced asymptomatic COVID-19. Our current findings may be used as the additional baseline criteria for selecting the donors of CCP for the management of COVID-19.

Actions (login required)

View Item